PT932613E - Expressao de bloqueio de factoes de virulencia em s. aureus - Google Patents

Expressao de bloqueio de factoes de virulencia em s. aureus

Info

Publication number
PT932613E
PT932613E PT97927727T PT97927727T PT932613E PT 932613 E PT932613 E PT 932613E PT 97927727 T PT97927727 T PT 97927727T PT 97927727 T PT97927727 T PT 97927727T PT 932613 E PT932613 E PT 932613E
Authority
PT
Portugal
Prior art keywords
aureus
expression
virulence
facts
blocking
Prior art date
Application number
PT97927727T
Other languages
English (en)
Inventor
Richard P Novick
Ji Guangyong
Beavis Ronald
Original Assignee
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York filed Critical Univ New York
Publication of PT932613E publication Critical patent/PT932613E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Air Conditioning Control Device (AREA)
  • Heat Treatment Of Steel (AREA)
  • Electrotherapy Devices (AREA)
  • Control Of Combustion (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
PT97927727T 1996-05-22 1997-05-22 Expressao de bloqueio de factoes de virulencia em s. aureus PT932613E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65122696A 1996-05-22 1996-05-22

Publications (1)

Publication Number Publication Date
PT932613E true PT932613E (pt) 2005-06-30

Family

ID=24612055

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97927727T PT932613E (pt) 1996-05-22 1997-05-22 Expressao de bloqueio de factoes de virulencia em s. aureus

Country Status (8)

Country Link
EP (1) EP0932613B1 (pt)
JP (1) JP2000511537A (pt)
AT (1) ATE290548T1 (pt)
AU (1) AU735283B2 (pt)
CA (1) CA2256465A1 (pt)
DE (1) DE69732709T2 (pt)
PT (1) PT932613E (pt)
WO (1) WO1997044349A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724859D0 (en) * 1997-11-26 1998-01-21 Univ Nottingham Compounds and their use as antibacterial agents
US7534857B2 (en) 1997-12-19 2009-05-19 Centegen, Inc. Methods and compositions for the treatment and prevention of staphylococcal infections
US6291431B1 (en) 1997-12-19 2001-09-18 Panorama Research Methods and compositions for the treatment and prevention of Staphylococcal infections
US7323179B2 (en) 1997-12-19 2008-01-29 Naomi Balaban Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections
US6337385B1 (en) 1998-06-24 2002-01-08 The Rockefeller University Staphylococcus peptides for bacterial interference
WO1999067286A2 (en) * 1998-06-24 1999-12-29 The Rockefeller University Novel staphylococcus peptides for bacterial interference
US6747129B1 (en) 1998-09-15 2004-06-08 The Regents Of The University Of California Target of RNAIII activating protein(TRAP)
EP1862549A3 (en) 1998-09-15 2008-02-13 Naomi Balaban Target of RNAIII activating protein (TRAP)
EP1188831B1 (en) * 1998-09-15 2007-12-05 Naomi Balaban Target of RNAIII activating protein (TRAP)
US20030050248A1 (en) * 2000-02-10 2003-03-13 Wright Susan C. Novel amino acid and peptide inhibitors of Staphylococcus virulence
CN1449251A (zh) * 2000-02-23 2003-10-15 吴羽化学工业株式会社 植物生长促进剂和植物生长促进方法
US7824691B2 (en) 2005-04-04 2010-11-02 Centegen, Inc. Use of RIP in treating staphylococcus aureus infections
CN101835484B (zh) * 2007-10-25 2014-07-16 斯克利普斯研究院 细菌群体感应的抗体介导性破坏
EP3072899B1 (en) 2015-03-23 2018-05-02 Eberhard Karls Universität Tübingen Novel anti-infective compound
WO2017136400A1 (en) * 2016-02-02 2017-08-10 Stc. Unm Vlp-based vaccines for targeting staphylococcus aureus secreted virulence factors
EP3675884A4 (en) * 2017-08-31 2021-08-11 The Regents of the University of California MOLECULAR BACTERIOTHERAPY TO CONTROL ENZYMATIC ACTIVITY OF THE SKIN
KR102286075B1 (ko) * 2019-09-27 2021-08-05 코스맥스 주식회사 스타필로코커스 렌투스 st-2 균주 및 그의 피부 상태 개선 용도
KR102195998B1 (ko) * 2019-09-27 2020-12-29 코스맥스 주식회사 스타필로코커스 시뮬란스 st-9 균주 및 그의 피부 상태 개선 용도
KR102199062B1 (ko) * 2019-09-27 2021-01-06 코스맥스 주식회사 스타필로코커스 자일로서스 st-10 균주 및 그의 피부 상태 개선 용도
CN118931767B (zh) * 2024-07-24 2025-03-25 内蒙古医科大学附属医院(内蒙古自治区心血管研究所) 一株纹带棒状杆菌nmgcs43及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996010579A1 (en) * 1994-10-04 1996-04-11 New York University Blocking expression of virulence factors in s. aureus

Also Published As

Publication number Publication date
EP0932613A4 (en) 2002-01-09
WO1997044349A1 (en) 1997-11-27
ATE290548T1 (de) 2005-03-15
CA2256465A1 (en) 1997-11-27
AU735283B2 (en) 2001-07-05
DE69732709D1 (de) 2005-04-14
JP2000511537A (ja) 2000-09-05
EP0932613B1 (en) 2005-03-09
DE69732709T2 (de) 2006-06-29
EP0932613A1 (en) 1999-08-04
AU3211797A (en) 1997-12-09

Similar Documents

Publication Publication Date Title
PT932613E (pt) Expressao de bloqueio de factoes de virulencia em s. aureus
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
NO982310L (no) Protegriner
WO2003099110A3 (en) Herbs and herbal combinations useful for the treatment of microbial infections
PE14199A1 (es) Agonistas de 5-ht1f
PT1056454E (pt) Utilizacao de compostos macrolido para o tratamento do glaucoma
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
EP0766674A4 (en) NEW HIV PROTEASE INHIBITORS
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
DE69938935D1 (de) Zyklische conotoxin-peptide
BR9711986A (pt) Compostos farmac-uticos
DE69729183T2 (de) Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen
DK1073436T3 (da) Forbedret fremgangsmåde til udryddelse af helicobacter pylori
BR0111785A (pt) Composições e métodos para tratamento de candidìase
WO2000063386A3 (en) Prevention, diagnosis and treatment of lyme disease
BG101145A (bg) Използване на /s/-аденозил-l-метионин /саме/ i неговите физиологично съвместими соли за лечение нареперфузионно увреждане, причинено от временна фокална исхемиа
EA200101171A1 (ru) Способ лечения инфекций, вызванных streptococcus pneumoniae
DE60024977D1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
WO2004064784A3 (en) Composition and method for preventing or treating a virus infection
WO1998014567A3 (en) Methods and compositions for inhibiting bacterial growth
ATE401349T1 (de) Monoklonale antikörper gegen das map-protein und verfahren zu dessen anwendung bei der behandlung bzw. prävention von infektionen